Results 261 to 270 of about 761,204 (307)
Some of the next articles are maybe not open access.
Growth Hormone Treatment in Children
Trends in Endocrinology & Metabolism, 1997GH therapy increases final height in GH-deficient children. Short-term growth acceleration is also seen in children with many other causes of shortness. This review covers the diagnosis of GH-deficiency (GHD) and the details of GH treatment and its long-term results in GH-deficient patients and in those with other conditions, including "idiopathic ...
openaire +2 more sources
Treatment of Growth Hormone Insufficiency
Developmental Pharmacology and Therapeutics, 1990Growth during childhood is growth hormone dependent and is modulated predominantly by the amplitude of the growth hormone secretory bursts while the frequency of these episodes remains relatively constant at 180-200 min. Optimisation of therapy for children with growth hormone insufficiency requires a clear definition of the dose of the growth hormone ...
openaire +2 more sources
Growth Hormone Treatment: Cancer Risk
Hormone Research in Paediatrics, 2004There have been concerns that growth hormone (GH) therapy may be associated with an increased risk of cancer. Although data are limited and conflicting, one recent report on cancer risk in individuals with no cancer history or risk factors for cancer who were treated with pituitary GH demonstrated a small increased risk of colon cancer and deaths from ...
openaire +2 more sources
Growth Hormone Treatment and Cancer Risk
Endocrinology and Metabolism Clinics of North America, 2007Increasing numbers of children receive growth hormone (GH) to treat a range of growth disorders, including those rendered GH deficient (GHD) by tumors or their treatment. Young persons with persistent growth hormone deficiency (GHD) and adults with severe GHD are also eligible to receive GH treatment.
Banerjee, Indraneel, Clayton, Peter E.
openaire +4 more sources
2013
Approximately 8–10 % of children born small for gestational age (SGA) do not show catch-up growth by the age of 2 years and older [1, 2], with approximately 10 % of all children born SGA still below the third percentile at the age of 8 years [3]. These children later have a reduced adult height [4].
openaire +1 more source
Approximately 8–10 % of children born small for gestational age (SGA) do not show catch-up growth by the age of 2 years and older [1, 2], with approximately 10 % of all children born SGA still below the third percentile at the age of 8 years [3]. These children later have a reduced adult height [4].
openaire +1 more source
Growth Hormone Treatment for Burned Children
Hormone Research, 1996Several growth hormones show promise in the treatment of burn injuries, particularly for paediatric patients. Animal studies and clinical trials indicate that growth hormones help modulate the devastating effects of the hypermetabolic response to burn injury and improve wound healing.
D N, Herndon +3 more
openaire +2 more sources
Growth Hormone Treatment and Adverse Events.
Pediatric endocrinology reviews : PER, 2017We compiled the major adverse events included in the Annual Research Reports of the Foundation for Growth Research published in and after 2000. We conducted a review of approximately 32,000 patients treated with growth hormone (GH) who subsequently developed leukemia and who were registered with the Foundation for Growth Research (from 1975 to December
Nishi, Yoshikazu, Tanaka, Toshiaki
openaire +2 more sources
Growth Hormone Treatment for Short Stature
New England Journal of Medicine, 1983Fifteen short but otherwise normal children, 4.3 to 15.5 years old, with heights greater than 3 S.D. below the mean value for age, growth rates less than or equal to 5.0 cm per year, and normal serum levels of immunoreactive growth hormone in response to provocative stimuli (peak greater than or equal to 10 ng per milliliter) were treated with ...
G, Van Vliet +3 more
openaire +2 more sources
Monitoring Growth Hormone Treatment
The Endocrinologist, 1996The use of growth hormone (GH) has expanded from the treatment of short stature due to GH deficiency (GHD) in children with open epiphyses to include growth failure due to chronic renal insufficiency (CRI) and Turner's syndrome (TS) as well as adults with GHD.
openaire +1 more source
Growth Hormone Treatment in Dilated Cardiomyopathy
Journal of Cardiac Surgery, 2001Treatment with human recombinant growth hormone (GH) has yielded conflicting results in patients with congestive heart failure. We analyzed the baseline somatotrophic axis in 50 patients with dilated cardiomyopathy. Then, a double-blind, randomized, placebo-controlled study of GH was performed.
A, Perrot +3 more
openaire +2 more sources